Stay updated on XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial
Sign up to get notified when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.

Latest updates to the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site. This appears to be an internal versioning change with no impact on the study information presented.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update without changes to primary content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; this minor update does not affect page content or study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no changes to study data or public content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a 'Show glossary' toggle and small formatting/label updates such as 'Last Update Submitted that Met QC Criteria' (capitalization), 'No FEAR Act Data' (section label), and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check99 days agoChange DetectedThe page revision history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed, a minor update to the page's documentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.